London, Wendy B.
Dana-Farber Cancer Institute,
United States
2025 Rank: 110184
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3350 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 110184 | 88409 |
| Total Cites | 2034 | 2300 |
| H-index | 21 | 22 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 1 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 77 | 83 |
| Number of Single+First+Last Authored Papers | 23 | 23 |
| Total Cites to Single+First+Last Authored Papers | 116 | 132 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1145 | 1201 |
| Ratio of Total Citations to Distinct Citing Papers | 1.78 | 1.92 |
| Self-Citation Percentage |
11.57%
|
|
London, Wendy B.
Dana-Farber Cancer Institute,
United States
2024 Rank: 92743
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3060 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 92743 | 94357 |
| Total Cites | 2018 | 2282 |
| H-index | 22 | 23 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 9 | 9 |
| Total Cites to Single+First Authored Papers | 83 | 90 |
| Number of Single+First+Last Authored Papers | 21 | 21 |
| Total Cites to Single+First+Last Authored Papers | 124 | 136 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1090 | 1168 |
| Ratio of Total Citations to Distinct Citing Papers | 1.85 | 1.95 |
| Self-Citation Percentage |
11.57%
|
|
London, Wendy B.
Harvard Medical School,
United States
2023 Rank: 90361
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3240 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 90361 | 84675 |
| Total Cites | 2024 | 2307 |
| H-index | 22 | 24 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 9 | 9 |
| Total Cites to Single+First Authored Papers | 87 | 97 |
| Number of Single+First+Last Authored Papers | 20 | 20 |
| Total Cites to Single+First+Last Authored Papers | 134 | 151 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1081 | 1163 |
| Ratio of Total Citations to Distinct Citing Papers | 1.87 | 1.98 |
| Self-Citation Percentage |
12.27%
|
|
London, Wendy B.
Dana-Farber Cancer Institute,
United States
2022 Rank: 94339
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3572 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 94339 | 93728 |
| Total Cites | 2000 | 2288 |
| H-index | 21 | 23 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 8 | 8 |
| Total Cites to Single+First Authored Papers | 78 | 82 |
| Number of Single+First+Last Authored Papers | 19 | 19 |
| Total Cites to Single+First+Last Authored Papers | 111 | 122 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1105 | 1197 |
| Ratio of Total Citations to Distinct Citing Papers | 1.81 | 1.91 |
| Self-Citation Percentage |
12.59%
|
|
London, Wendy B.
Harvard Medical School,
United States
2021 Rank: 102964
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3664 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 102964 | 102236 |
| Total Cites | 2686 | 3138 |
| H-index | 25 | 27 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 8 | 8 |
| Total Cites to Single+First Authored Papers | 126 | 138 |
| Number of Single+First+Last Authored Papers | 17 | 17 |
| Total Cites to Single+First+Last Authored Papers | 160 | 184 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1496 | 1636 |
| Ratio of Total Citations to Distinct Citing Papers | 1.80 | 1.92 |
| Self-Citation Percentage |
14.40%
|
|
London, Wendy B.
Dana-Farber Cancer Institute,
United States
2020 Rank: 117819
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 4111 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 117819 | 107999 |
| Total Cites | 1909 | 2274 |
| H-index | 20 | 23 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 8 | 8 |
| Total Cites to Single+First Authored Papers | 71 | 86 |
| Number of Single+First+Last Authored Papers | 15 | 15 |
| Total Cites to Single+First+Last Authored Papers | 84 | 102 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1100 | 1206 |
| Ratio of Total Citations to Distinct Citing Papers | 1.74 | 1.89 |
| Self-Citation Percentage |
16.05%
|
|